Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
NMDAE plus AO
DRUG:
NMDAE plus Placebo Cap
Sponsor
China Medical University Hospital
Collaborators
[object Object]